Catheter Precision Converts Series A Preferred Stock

An update from Catheter Precision (VTAK) is now available.

On July 24, 2024, a company successfully converted all outstanding Series A Convertible Preferred Stock into 25,000 shares of common stock, with the event taking place the previous day. This conversion, exempt from commission charges under a specific securities act provision, led to the registration of the new common stock for resale. Consequently, no Series A Preferred shares remain outstanding following this transaction.

Learn more about VTAK stock on TipRanks’ Stock Analysis page.